Datamonitor expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest growth is expected in the non-insulin market, the insulin market will continue to dominate, generating revenues of $224m 10 years from now.

Reasons to Purchase

*Identify key opportunities and threats that will impact the use and uptake of new and existing products

*Quantify the future size and scope of the Australian antidiabetics market and predict the performance of key compounds

*Understand critical success factors in growing and defending antidiabetic brand franchises from new entrants and generics

What are Interactive Models?

Interactive Models are databases that contain historical and forecast market and product data, industry figures and forecasts in an excel format that's easy to search and manipulate.

How do Interactive Models work?

The raw data for the model sits at the back end of the excel deliverable. At the front end, the client can add or remove categories to the data set already provided, manipulate geographies & categories, thus make their own analysis and derive results. This enhances the functionality of the model and makes it interactive.

Our Interactive Models cover a variety of topics across the Pharmaceutical, Technology, Automotive, Retail and Energy industries.

Why buy an Interactive Model?

An Interactive Model allows you to...

Manipulate the data to suit your research needs.
Access raw and comprehensive data.
Gain easily accessible data which can be used in any format e.g. Power Point, Word, Excel.
Benefit from the Universal Excel deliverable format.